Tenofovir in second-line ART in Zambia and South Africa: collaborative analysis of cohort studies

BORIS DOI
Date of Publication
2012
Publication Type
Article
Division/Institute

Institut für Sozial- ...

Contributor
Mulenga, Lloyd
Hoffmann, Christopher J
Wood, Robin
Chaweza, Thom
Brennan, Alana
Prozesky, Hans
Garone, Daniela
Giddy, Janet
Chimbetete, Cleophas
Boulle, Andrew
IeDEA Southern Africa Collaboration
Subject(s)

600 - Technology::610...

Series
Journal of acquired immune deficiency syndromes JAIDS
ISSN or ISBN (if monograph)
0894-9255
Publisher
Lippincott Williams & Wilkins
Language
English
Publisher DOI
PubMed ID
22743595
Description
Tenofovir (TDF) is increasingly used in second-line antiretroviral treatment (ART) in sub-Saharan Africa. We compared outcomes of second-line ART containing and not containing TDF in cohort studies from Zambia and the Republic of South Africa (RSA).
Handle
Show full item
File(s)
FileFile TypeFormatSizeLicensePublisher/Copright statementContent
00126334-201209010-00006.pdftextAdobe PDF452.13 KBpublisherpublished restricted
Wandeler JAIDS 2012_61_manuscript.pdftextAdobe PDF918.06 KBpublisheracceptedOpen